$0.98
▲ +$0.03
(+3.16%)
Vol 61K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$19.6M
ROE
-103.4%
Margin
-10.0%
D/E
79.15
Beta
0.73
52W
$1–$2
Wall Street Consensus
7 analysts · Apr 20262
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 80.0%
Next Report
May 11, 2026
EPS Estimate: $-0.07
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.07 | — | — |
| Dec 2025 | $-0.02 | $-0.01 | +$0.01 |
| Sep 2025 | $-0.06 | $-0.09 | $-0.03 |
| Jun 2025 | $-0.09 | $-0.06 | +$0.03 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $11.6M | $12.7M | $11.9M | $13.6M | $12.5M |
| Net Income | -$1.9M | -$834K | -$1.7M | -$994K | -$1.6M |
Fundamentals Trend
| Metric | 2025-06-28 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -123.6% | -180.4% | -123.6% | -123.6% | -123.6% | -103.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -7.3% | -14.6% | -10.9% | -10.9% | -10.9% | -10.0% |
| Gross Margin | 34.5% | 41.2% | 39.5% | 39.5% | 39.5% | 38.2% |
| D/E Ratio | 60.65 | 53.18 | 60.65 | 60.65 | 60.65 | 79.15 |
| Current Ratio | 1.96 | 1.95 | 1.96 | 1.96 | 1.96 | 1.94 |
Key Ratios
ROA (TTM)
-16.5%
P/S (TTM)
0.39
P/B
13.8
EPS (TTM)
$-0.30
CF/Share
$-0.34
Rev Growth 3Y
-3.4%
52W High
$1.89
52W Low
$0.78
$0.78
52-Week Range
$1.89
Financial Health
Free Cash Flow
-$1.2M
Net Debt
-$788K
Cash
$5.6M
Total Debt
$4.8M
As of Sep 30, 2025
How does IRIX compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
IRIX valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
0.4
▼
85%
below
peers
(2.6)
vs Peers
vs Industry
Undervalued
P/B ratio
13.8
▲
397%
above
peers
(2.8)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
IRIX profitability vs Health Care peers
ROE
-103.4%
▼
168%
below
peers
(-38.5%)
vs Peers
vs Industry
Weak
Net margin
-10.0%
▲
59%
above
peers
(-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
38.2%
▼
28%
below
peers
(52.9%)
vs Peers
vs Industry
Weak
ROA
-16.5%
▲
22%
above
peers
(-21.2%)
vs Peers
vs Industry
Below avg
IRIX financial health vs Health Care peers
D/E ratio
79.2
▲
311%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
1.9
▼
10%
below
peers
(2.2)
vs Peers
vs Industry
In line
Beta
0.7
▼
31%
below
peers
(1.1)
vs Peers
vs Industry
More volatile
IRIX fundamentals radar
IRIX
Peer median
Industry
IRIX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IRIX vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
DIZON ROMEO R
Chief Financial Officer · Mar 06
1110 shs
DIZON ROMEO R
Chief Financial Officer · Feb 17
2200 shs
DIZON ROMEO R
Chief Financial Officer · Feb 12
1500 shs
DIZON ROMEO R
Chief Financial Officer · Feb 10
1000 shs
DIZON ROMEO R
Chief Financial Officer · Feb 03
2500 shs
DIZON ROMEO R
Chief Financial Officer · Jan 29
1101 shs
DIZON ROMEO R
Chief Financial Officer · Jan 28
1300 shs
DIZON ROMEO R
Chief Financial Officer · Jan 27
3385 shs
DIZON ROMEO R
Chief Financial Officer · Jan 26
1243 shs
DIZON ROMEO R
Chief Financial Officer · Jan 23
5221 shs
Last 90 days
Top Holders
Top 5: 13.65%Paragon Associates & Parago…
5.82%
$1.0M
Vanguard Group Inc
3.37%
$584K
Renaissance Technologies, L…
2.16%
$375K
Weber Capital Management LL…
1.51%
$262K
Geode Capital Management, L…
0.79%
$137K
As of Dec 31, 2025